載入...
ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942
The CDK7 inhibitors (CDK7i) ICEC0942 and THZ1, are promising new cancer therapeutics. Resistance to targeted drugs frequently compromises cancer treatment. We sought to identify mechanisms by which cancer cells may become resistant to CDK7i. Resistant lines were established through continuous drug s...
Na minha lista:
| 發表在: | Oncogene |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6962093/ https://ncbi.nlm.nih.gov/pubmed/31530935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-019-1008-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|